soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π SELECT Trial
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 6 - Oct 11








:format(webp))


















![Slimefoot and Squee (PRE-450) - March of the Machine Commander: (Showcase) Fire[x2]](https://cdn.shopify.com/s/files/1/0634/7194/3915/files/c6f777b0-2f35-4333-8f54-7ceeeac2ec83.png?v=1757164515)